CRNX — Crinetics Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $9.00bn
- $7.80bn
- $7.70m
Brief: Crinetics Pharmaceuticals Q1 Net Income USD -96.774 Million
Brief: Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation Of Marketing Authorization Application (MAA) And Orphan Drug Designation (ODD) For Paltusotine In Acromegaly
U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences
U.S. STOCKS ON THE MOVE-Affirm, Trump Media, Comstock
U.S. STOCKS ON THE MOVE-CrowdStrike, Scholar Rock, Cloudflare
Stifel initiates Crinetics Pharma with 'buy' on FDA approval prospects
Brief: Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Morgan Stanley initiates Crinetics with 'outperform' on catalyst rich 2025
Crinetics Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Crinetics Pharmaceuticals Q4 Net Income USD -80.595 Million
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group
U.S. STOCKS ON THE MOVE-Biohaven, Ecolab, Firefly
U.S. STOCKS ON THE MOVE-Humana, S&P Global, Charles Schwab
Crinetics gains after TD Cowen starts with 'buy' on optimism for lead drugs
Brief: Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Crinetics Pharmaceuticals Appoints Isabel Kalofonos As Chief Commercial Officer
Crinetics Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Crinetics Pharmaceuticals Q3 Net Income USD -76.828 Million